Experience. Commitment. Results.
IGM Biosciences, Inc. (NASDAQ: IGMS) related to its merger to Concentra Biosciences, LLC for $1.247 in cash per share of IGM Biosciences common stock, plus one non-tradeable contingent value right, which represents the right to receive: (i) 100% of the closing net cash of IGM Biosciences in excess of $82.0 million; and (ii) 80% of any … Read more
Big 5 Sporting Goods Corp. (NASDAQ: BGFV) related to its sale to a partnership comprised of Worldwide Golf and Capitol Hill for $1.45 share in cash without interest to Big 5 Sporting Goods shareholders.
GMS Inc. (NYSE: GMS) related to its sale to SRS Distribution for $110.00 per share without interest to GMS shareholders.
Couchbase, Inc. (NASDAQ: BASE) related to its sale to Haveli Investments for $24.50 per share in cash without interest to Couchbase shareholders.
SpartanNash Company (NASDAQ: SPTN) related to its sale to C&S Wholesale Grocers for $26.90 per share in cash without interest to SpartanNash shareholders.
Enzo Biochem, Inc. (OTCMKTS: ENZB) related to its sale to Battery Ventures for $0.70 per share in cash without interest to Enzo shareholders.
DNOW Inc. (NYSE: DNOW) related to its merger with MRC Global Inc. Upon completion of the proposed transaction, current DNOW shareholders will own approximately 56.5% of the combined company on a fully diluted basis.
Sage Therapeutics, Inc. (NASDAQ: SAGE) related to its sale to Supernus Pharmaceuticals, Inc. Upon completion of the proposed transaction, current Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable (i) $0.50 the first commercial sale of the drug Zurzuvae … Read more
Turnstone Biologics Corp. (NASDAQ: TSBX) related to its sale to XOMA Royalty Corporation in which existing Turnstone shareholders will receive $0.34 in cash per share and one non-transferable contingent value right.
Guaranty Bancshares, Inc. (NYSE: GNTY) related to its sale to Glacier Bancorp, Inc. Upon completion of the proposed transaction, existing Guaranty shareholders will receive 1.0000 share of Glacier common stock for each share of Guaranty (subject to certain adjustments).